TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

Current Biology

Volumn 7, Issue 9, 1997, Pages 693-696

  Screaton, Gavin R ^a   Mongkolsapaya, Juthathip ^a   Xu, Xiao Ning ^a   Cowper, Alison E ^a   McMichael, Andrew J ^a   Bell, John I ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0031239984     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00297-1     Document Type: Article

References (19)

1. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al.: The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
2. Wiley RR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholl JK, et al.: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
3. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996, 271:12687-12690.
4. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
5. Screaton GR, Xu XX, Olsen AL, Cowper AE, Tan R, McMichael AJ, et al.: LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 1997, 94:4615-4619.
6. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, et al.: Signal transduction by DR3, a death domain-containing receptor related to TNF-R1 and CD95. Science 1996, 274:990-992.
7. Kitson J, Raven T, Jiang Y-P, Goeddel DV, Giles KM, Pun K-T, et al.: A death-domain-containing receptor that mediates apoptosis. Nature 1996, 384:372-375.
8. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, et al.: Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 1996, 6:1669-1676.
9. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, et al.: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 1997, 6:79-88.
10. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JAT:CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis sarcoma viruses and mediates apoptosis. Cell 1996, 87:845-855.
11. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, et al.: Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431-445.
12. Naismith JH, Devine TQ, Kohno T, Sprang SR: Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4:1251-1262.
13. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A: Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 1996, 6:750-752.
14. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer AY, Camonis JH, et al.: Self-association of the 'death domains' of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem 1995, 270:387-391.
15. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 1994, 8:1613-1626.
16. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178.
17. Braun MY, Lowin B, French L, Acha Orbea H, Tschopp J: Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996, 183:657-661.
18. Xu X, Screaton GR, Gotch FM, Dong T, Tan R, Almond N, et al.: Evasion of CTL responses by Nef-dependent induction of Fas ligand expression on simian immunodeficiency virus-infected cells. J Exp Med 1997, 186:1-10.
19. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, et al.: Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996, 274:1363-1366.